Susquehanna International Group, LLP Soleno Therapeutics Inc Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.14 - $0.23 $303 - $498	2,166 Added 14.76%	16,843 $3,000
Q1 2022 May 16, 2022	SELL	$0.22 - $0.47 $26,854 - $57,371	-122,066 Reduced 89.27%	14,677 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.41 - $0.91 $12,648 - $28,073	30,850 Added 29.13%	136,743 $56,000
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $5,674 - $7,944	-7,093 Reduced 6.28%	105,893 $97,000
Q2 2021 Aug 11, 2021	BUY	$0.97 - $1.32 $35,678 - $48,552	36,782 Added 48.27%	112,986 $129,000
Q1 2021 May 17, 2021	BUY	$1.24 - $3.3 $46,464 - $123,654	37,471 Added 96.74%	76,204 $96,000
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $2,532 - $3,507	1,573 Added 4.23%	38,733 $75,000
Q3 2020 Nov 16, 2020	SELL	$1.71 - $2.51 $68,759 - $100,927	-40,210 Reduced 51.97%	37,160 $93,000
Q1 2020 May 15, 2020	BUY	$1.64 - $3.85 $100,322 - $235,512	61,172 Added 377.65%	77,370 $184,000
Q4 2019 Feb 14, 2020	BUY	$1.35 - $2.95 $21,867 - $47,784	16,198 New	16,198 $48,000
Q1 2018 May 15, 2018	SELL	$1.56 - $2.12 $25,264 - $34,333	-16,195 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.39 - $2.73 $22,511 - $44,212	16,195	16,195 $29,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.